By News Desk
Updated: November 12, 2025
The journey through a cancer diagnosis is rarely a solitary path. For Tori Ashman, a mother and athlete, the battle against Stage 1B invasive ductal carcinoma became a testament to the power of "community in motion." Her story highlights the critical intersection between grassroots community organizations like Mamanet and specialized healthcare networks like Sharsheret, illustrating how psychosocial support and early detection remain the twin pillars of modern oncology survival.
Main Facts: A Dual Support System for Survival
Tori Ashman’s experience underscores two major themes in contemporary women’s health: the efficacy of culturally competent support and the life-saving potential of proactive screening. Diagnosed in February 2023, Ashman navigated her treatment not just through medical protocols, but through a robust support system comprised of her Mamanet sports team and Sharsheret, a national non-profit organization dedicated to supporting Jewish women and families facing breast and ovarian cancer.
Sharsheret, which means "chain" in Hebrew, has provided services to more than 275,000 individuals across the United States. Their model integrates clinical expertise with peer-led emotional support, a combination that Ashman identifies as pivotal to her recovery. Simultaneously, Mamanet—an international mothers’ catchball league—provided the social scaffolding necessary to maintain mental health during the rigors of treatment.
The core of Ashman’s message is a clarion call for early detection. With Stage 1 breast cancer boasting a five-year survival rate of approximately 99%, her narrative serves as a journalistic case study in how "catching it early" transforms a potentially terminal prognosis into a manageable medical journey.
Chronology: From the First Mammogram to Survivorship
The timeline of Tori Ashman’s health journey is marked by a decade of vigilance, illustrating the "watchful waiting" period many women experience before a definitive diagnosis.
2015–2022: The Cycle of Vigilance
Upon turning 40, Ashman initiated her routine mammogram screenings. This began a grueling, multi-year cycle of medical scrutiny. While her initial images led to a lumpectomy, the findings were non-cancerous at the time. However, the subsequent years were defined by what Ashman describes as a "subscription box" of medical interventions: annual mammograms followed by ultrasounds, which frequently necessitated biopsies. This period of high-risk monitoring is common for women with dense breast tissue or a family history of the disease.
February 2023: The Diagnosis
The "cycle of vigilance" ended in February 2023 when a biopsy confirmed Stage 1B invasive ductal carcinoma. Invasive ductal carcinoma (IDC) is the most common form of breast cancer, beginning in the milk ducts and spreading to the surrounding breast tissue. At Stage 1B, the cancer is caught early, often involving a small tumor and limited, if any, lymph node involvement. This diagnosis prompted Ashman to activate her support networks immediately.
2023–2024: Treatment and Community Mobilization
Following her diagnosis, Ashman leaned heavily on Sharsheret for clinical guidance and peer connection. Simultaneously, her Mamanet team transitioned from a recreational outlet to a frontline support group. The league organized "tribute games" and coordinated logistical support, including meals and emotional check-ins, while Ashman’s family—including her sister, who is battling Stage 4 breast cancer—provided the domestic foundation for her recovery.
2025: Advocacy and Reflection
Now in the survivorship phase, Ashman has transitioned from a patient to an advocate. Her focus has shifted toward public speaking and encouraging women to overcome the "fear of the phone call" to prioritize preventative screenings.
Supporting Data: The Impact of Early Detection and Cultural Risk
The clinical significance of Ashman’s story is backed by rigorous oncological data. According to the American Cancer Society, when breast cancer is detected in the localized stage (no sign that the cancer has spread outside the breast), the five-year relative survival rate is 99%.
The Ashkenazi Connection
Sharsheret’s role is particularly vital due to the specific genetic risks within the Jewish community. One in 40 individuals of Ashkenazi Jewish descent carries a BRCA1 or BRCA2 gene mutation—a rate ten times higher than that of the general population. These mutations significantly increase the lifetime risk of developing breast and ovarian cancer. Sharsheret’s specialized focus provides genetic counseling and tailored resources that address these specific biological and cultural nuances.
Psychosocial Outcomes
Data from the Journal of Clinical Oncology suggests that patients with strong social support networks experience lower levels of distress and better adherence to treatment protocols. Sharsheret’s "Busy Boxes," which Ashman utilized, are designed to help mothers explain their diagnosis to children through play and age-appropriate materials. This resource addresses the "collateral damage" of cancer—the emotional toll on the family unit—which is often overlooked in traditional clinical settings.
Official Responses: Philosophy of Support
The organizations mentioned in Ashman’s journey operate on philosophies that emphasize the "whole person" rather than just the pathology of the disease.
Sharsheret’s Clinical Mandate
In statements regarding their mission, Sharsheret emphasizes that they are not a "Jewish-only" organization, though they specialize in the Jewish cultural experience. Their clinical staff focuses on "holding the hand" of the patient through every scan and sleepless night. Their official stance is that no woman should face a diagnosis in isolation, providing a "safety net" that includes financial assistance, nutritional counseling, and mental health support.
Mamanet: Community in Motion
Mamanet, the mothers’ catchball league, views sports as a vehicle for social cohesion. The league’s philosophy is built on the idea that when a mother is active and supported, the entire family and community benefit. In Ashman’s case, the Mamanet league’s response—dedicating games to her recovery—aligns with their organizational goal of creating a "sisterhood" that transcends the boundaries of the court.
Implications: The Future of Integrated Cancer Care
Tori Ashman’s journey offers several profound implications for the future of public health and cancer advocacy.
1. The De-stigmatization of Screening
Ashman’s narrative addresses the "anxiety of the unknown." By framing her frequent biopsies as a "subscription box," she uses humor to de-stigmatize the often-terrifying process of medical monitoring. The implication for public health is clear: normalized, frequent screening must be rebranded as a tool of empowerment rather than a source of dread.
2. The Role of Specialized Non-Profits
The success of Sharsheret highlights a gap in the standard healthcare system. While hospitals provide the surgery and chemotherapy, non-profits provide the survivability. The integration of organizations like Sharsheret into the standard care plan allows for a more holistic approach to oncology, addressing genetic predispositions and family dynamics that a 15-minute oncology appointment cannot.
3. Sports as a Mental Health Intervention
The Mamanet component of the story suggests that recreational sports leagues can serve as vital mental health interventions. For Ashman, the "matching shirts and coordinated warm-ups" of her team were not just for show; they represented a disciplined, reliable community that remained intact when her health felt fragile. This underscores the importance of maintaining social identities—as an athlete, a teammate, and a friend—outside of the "patient" identity.
4. The "Normalcy" of Early Detection
Perhaps the most significant implication is the preservation of "normalcy." Ashman notes that early detection allowed her to continue making dinner, going to work, and showing up for practice. This shifts the cancer narrative from one of total life interruption to one of manageable health maintenance. As screening technology improves, the goal of the medical community is to ensure that more women have the same opportunity to "live their life, not just fight for it."
Conclusion: A Call to Action
Tori Ashman’s story concludes with a direct appeal to the public. The 99% survival rate for early-stage breast cancer is not just a statistic; it is a mandate for action. The synergy between her family, her Mamanet teammates, and the clinicians at Sharsheret created a framework where healing was possible.
As Ashman continues her life on the court and in the clinic, her message remains steadfast: "True strength comes from community. Together, we are strong. We are survivors. We are sisters. And none of us ever have to play this game alone."
For those seeking support or information regarding breast and ovarian cancer risks, Sharsheret remains a primary resource, offering a "chain" of support that links medical knowledge with human compassion.
Resources:
Individuals impacted by breast or ovarian cancer can contact Sharsheret at [email protected] for peer support, genetic counseling, and educational resources.
About the Author
